Endothelial Gab1 deletion accelerates angiotensin II-dependent vascular inflammation and atherosclerosis in apolipoprotein E knockout mice

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 2031-2040

  Higuchi, Kaori ^a   Nakaoka, Yoshikazu ^a   Shioyama, Wataru ^a   Arita, Yoh ^a   Hashimoto, Takahiro ^a   Yasui, Taku ^a   Ikeoka, Kuniyasu ^a   Kuroda, Tadashi ^a   Minami, Takashi ^c   Nishida, Keigo ^b   Fujio, Yasushi ^d   Yamauchi Takihara, Keiko ^a   Shirai, Mikiyasu ^e   Mochizuki, Naoki ^e   Komuro, Issei ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atherosclerosis; Endothelium; Grb2 associated binder 1 (Gab1); Inflammation; Kr ppel like factor (KLF)

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CHOLESTEROL; CYTOKINE; DOCKING PROTEIN; GLUCOSE; GRB 2 ASSOCIATED BINDER 1; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ANEURYSM; ARTICLE; ATHEROSCLEROSIS; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE DELETION; HISTOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; VASCULITIS;

ANGIOTENSIN II; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DOWN-REGULATION; FEMALE; GENE DELETION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; VASCULITIS;

EID: 84864383678     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1507     Document Type: Article

References (40)

1. Gu H, Neel BG. The "Gab" in signal transduction. Trends Cell Biol 2003; 13: 122-130.
2. Wohrle FU, Daly RJ, Brummer T. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 2009; 7: 22.
3. Nakaoka Y, Nishida K, Fujio Y, Izumi M, Terai K, Oshima Y, et al. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ Res 2003; 93: 221-229.
4. Nakaoka Y, Shioyama W, Kunimoto S, Arita Y, Higuchi K, Yamamoto K, et al. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene. J Mol Cell Cardiol 2010; 49: 157-164.
5. Shioyama W, Nakaoka Y, Higuchi K, Minami T, Taniyama Y, Nishida K, et al. Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-Met signaling. Circ Res 2011; 108: 664-675.
6. Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M, Hirano T. Role of Gab1 in heart, placenta, and skin development and growth factorand cytokine-induced extracellular signal-regulated kinase mitogenactivated protein kinase activation. Mol Cell Biol 2000; 20: 3695-3704.
7. Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I, et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 2000; 150: 1375-1384.
8. Bard-Chapeau EA, Yuan J, Droin N, Long S, Zhang EE, Nguyen TV, et al. Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection. Mol Cell Biol 2006; 26: 4664-4674.
9. Bard-Chapeau EA, Hevener AL, Long S, Zhang EE, Olefsky JM, Feng GS. Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action. Nat Med 2005; 11: 567-571.
10. Nakaoka Y, Nishida K, Narimatsu M, Kamiya A, Minami T, Sawa H, et al. Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling. J Clin Invest 2007; 117: 1771-1781.
11. Weng T, Mao F, Wang Y, Sun Q, Li R, Yang G, et al. Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis. J Cell Sci 2010; 123: 682-689.
12. Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res 2007; 100: 1686-1695.
13. Das H, Kumar A, Lin Z, Patino WD, Hwang PM, Feinberg MW, et al. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci USA 2006; 103: 6653-6658.
14. Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002; 100: 1689-1698.
15. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006; 116: 49-58.
16. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 2005; 280: 26714-26719.
17. Sako K, Fukuhara S, Minami T, Hamakubo T, Song H, Kodama T, et al. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J Biol Chem 2009; 284: 5592-5601.
18. Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 2005; 112: 720-726.
19. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005; 96: e48-e57.
20. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 2004; 199: 1305-1315.
21. Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, et al. Kruppellike factor 4 regulates endothelial inflammation. J Biol Chem 2007; 282: 13769-13779.
22. Ohnesorge N, Viemann D, Schmidt N, Czymai T, Spiering D, Schmolke M, et al. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J Biol Chem 2010; 285: 26199-26210.
23. Homeister JW, Patterson C. Zinc fingers in the pizza pie aorta. Circ Res 2008; 103: 687-689.
24. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in Atherosclerosis: Transition From Theory to Practice. Circ J 2010; 74: 213-220.
25. Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
26. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105: 1605-1612.
27. Daugherty A, Rateri DL, Cassis LA. Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans. Ann N Y Acad Sci 2006; 1085: 82-91.
28. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo. Dev Biol 2001; 230: 230-242.
29. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10: 513-526.
30. Yamamoto R, Akazawa H, Ito K, Toko H, Sano M, Yasuda N, et al. Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-deficient mice. Circ J 2007; 71: 1958-1964.
31. Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, et al. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis. Circulation 2009; 120: 2470-2477.
32. Zhang YL, Naggar JC, Welzig CM, Beasley D, Moulton KS, Park HJ, et al. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice possible role of ERK. Arterioscler Thromb Vasc Biol 2009; 29: 1764-1771.
33. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001; 134: 865-870.
34. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-1262.
35. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998; 18: 842-851.
36. Gimbrone MA, Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Annals NY Acad Sci 1990; 598: 77-85.
37. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chirosso G, et al. Direct expression cloning of vascular cell-adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
38. Heo KS, Fujiwara K, Abe J. Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction. Circ J 2011; 75: 2722-2730.
39. Jin ZG, Wong C, Wu J, Berk BC. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. J Biol Chem 2005; 280: 12305-12309.
40. Atkins GB, Wang Y, Mahabeleshwar GH, Shi H, Gao H, Kawanami D, et al. Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis. Circ Res 2008; 103: 690-693.